Tectonic Therapeutic, Inc.
TECX
$34.91
$0.932.74%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.88% | 22.20% | 7.03% | -6.71% | 18.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.45% | 49.20% | 53.78% | 11.47% | 95.53% |
| Operating Income | -8.45% | -49.20% | -53.78% | -11.47% | -95.53% |
| Income Before Tax | -16.84% | -58.69% | -53.33% | -7.44% | -50.01% |
| Income Tax Expenses | -92.11% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.51% | -58.69% | -55.39% | -7.44% | -57.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.51% | -58.69% | -55.39% | -7.44% | -57.71% |
| EBIT | -8.45% | -49.20% | -53.78% | -11.47% | -95.53% |
| EBITDA | -8.83% | -50.50% | -57.11% | -12.15% | -98.39% |
| EPS Basic | -9.84% | -45.07% | -22.80% | 15.44% | 75.35% |
| Normalized Basic EPS | -15.08% | -45.06% | -21.17% | 15.43% | 76.55% |
| EPS Diluted | -9.84% | -45.07% | -22.80% | 15.44% | 75.35% |
| Normalized Diluted EPS | -15.08% | -45.06% | -21.17% | 15.43% | 76.55% |
| Average Basic Shares Outstanding | 1.52% | 9.39% | 26.54% | 27.05% | 539.75% |
| Average Diluted Shares Outstanding | 1.52% | 9.39% | 26.54% | 27.05% | 539.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |